| Original language | English (US) |
|---|---|
| Pages (from-to) | 827-854.e3 |
| Journal | Gastrointestinal endoscopy |
| Volume | 95 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2022 |
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Gastroenterology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Gastrointestinal endoscopy, Vol. 95, No. 5, 05.2022, p. 827-854.e3.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - American Society for Gastrointestinal Endoscopy guideline on screening for pancreatic cancer in individuals with genetic susceptibility
T2 - methodology and review of evidence
AU - Calderwood, Audrey H.
AU - Sawhney, Mandeep S.
AU - Thosani, Nirav C.
AU - Rebbeck, Timothy R.
AU - Wani, Sachin
AU - Canto, Marcia I.
AU - Fishman, Douglas S.
AU - Golan, Talia
AU - Hidalgo, Manuel
AU - Kwon, Richard S.
AU - Riegert-Johnson, Douglas L.
AU - Sahani, Dushyant V.
AU - Stoffel, Elena M.
AU - Vollmer, Charles M.
AU - Al-Haddad, Mohammad A.
AU - Amateau, Stuart K.
AU - Buxbaum, James L.
AU - DiMaio, Christopher J.
AU - Fujii-Lau, Larissa L.
AU - Jamil, Laith H.
AU - Jue, Terry L.
AU - Law, Joanna K.
AU - Lee, Jeffrey K.
AU - Naveed, Mariam
AU - Pawa, Swati
AU - Storm, Andrew C.
AU - Qumseya, Bashar J.
N1 - Funding Information: We thank Emily Groesbeck and Wenora Johnson, 2 patient representatives from the Facing Hereditary Cancer Empowered, an advocacy organization for families facing hereditary cancers, for participating in our panel. We also thank Dr Anne Marie Lennon, Dr Emad Qayed, Dr Ajay Pal Singh, and Dr Jenifer Lightdale for their review of this document. This guideline was funded exclusively by the American Society for Gastrointestinal Endoscopy; no outside funding was received to support the development of this guideline. Funding Information: The following authors disclosed financial relationships: M. S. Sawhney: Stockholder with Allurion Technology, Inc; research support and food and beverage compensation from Olympus Corporation of the Americas and Boston Scientific Corporation. N. C. Thosani: Consultant for and travel and food and beverage compensation from Boston Scientific Corporation; consultant for TaeWoong Medical; consultant for and research support, travel, and food and beverage compensation from Pentax of America, Inc; royalties from UpToDate; research support and food and beverage compensation from Endogastric Solutions; speaker for and food and beverage compensation from AbbVie, Inc; food and beverage compensation from Covidien LP; advisory board for ColubrisMX Inc. S. Wani: Consultant for and food and beverage compensation from Boston Scientific Corporation; consultant for Medtronic, Exact Sciences, and Interpace; research support from Cook Medical LLC; food and beverage compensation from Olympus America Inc; advisory board for Cernostics. M. I. Canto: Consultant for Exact Sciences; research support and food and beverage compensation from Endogastric Solutions and Pentax of America, Inc; has received food and beverage compensation from Boston Scientific Corporation, AbbVie, Inc, Daiichi Sankyo Inc, Merck Sharp & Dohme Corporation, and Shionogi Inc; royalties from UpToDate. D. S. Fishman: Food and beverage compensation from AbbVie, Inc and Boston Scientific Corporation. T. Golan: Consultant for AbbVie Inc, Teva Pharmaceutical Industries Ltd, and Bayer AG; consultant for and research support from AstraZeneca and Merck Sharp & Dohme Corp. M. Hidalgo: Stock and other ownership interests in Nelum Corp and Champions Oncology; stock and honoraria from Agenus and InxMed; research support from BiolineRx, Erytech Pharma, BioExcell, and TOP Alliance Biosciences; travel compensation from Bayer HealthCare Pharmaceuticals Inc; food and beverage compensation from Boehringer Ingelheim Pharmaceuticals, Inc, Pfizer Inc, and Sunovion Pharmaceuticals Inc. R. S. Kwon: Travel compensation from C2 Therapeutics, Inc; food and beverage compensation from Covidien LP. D. V. Sahani: Travel compensation and food and beverage compensation from GE Healthcare; food and beverage compensation from Abbott Laboratories. M. A. Al-Haddad: Research support and food and beverage compensation from Boston Scientific Corporation. S. K. Amateau: Consultant for and travel and food and beverage compensation from Boston Scientific Corporation and Olympus America Inc; consultant for and food and beverage compensation from Cook Medical LLC; consultant for Endo-Therapeutics, Hemostasis LLC, Merit Medical Systems Inc, and Steris Corporation. J. L. Buxbaum: Consultant for and research support, travel, and food and beverage compensation from Olympus America Inc; consultant for and travel and food and beverage compensation from Boston Scientific Corporation; consultant for Eagle Pharmaceuticals, Inc and Cook Incorporated; research support from Medtronic USA, Inc; food and beverage compensation from Covidien LP and AbbVie, Inc. C. J. DiMaio: Consultant for and travel and food and beverage compensation from Boston Scientific Corporation; consultant for Covidien LP and AbbVie, Inc; food and beverage compensation from Cook Medical LLC. L. L. Fujii-Lau: Research support from Cook Medical LLC; travel compensation from Ovesco; food and beverage compensation from Covidien LP and Boston Scientific Corporation. L. H. Jamil: Honoraria, travel compensation, and food and beverage compensation from Aries Pharmaceuticals, Inc; food and beverage compensation from AbbVie, Inc and Olympus America, Inc. T. L. Jue: Food and beverage compensation from Boston Scientific Corporation. J. Law has received food and beverage compensation from Cook Medical LLC. J. K. Lee: Research support from Pentax of America, Inc.. S. Pawa: Educational support from Alexion Pharmaceuticals, Inc; food and beverage compensation from Cook Medical LLC. A. C. Storm: Consultant for and travel and food and beverage compensation from Apollo Endo Surgery US Inc; consultant for Endo-TAGSS and Enterasense; data/safety monitoring from Erbe USA Inc and GI Dynamics; research support and food and beverage compensation from Boston Scientific Corporation. B. J. Qumseya: Food and beverage compensation from Boston Scientific Corporation and GlaxoSmithKline, LLC.
PY - 2022/5
Y1 - 2022/5
UR - https://www.scopus.com/pages/publications/85125730891
UR - https://www.scopus.com/pages/publications/85125730891#tab=citedBy
U2 - 10.1016/j.gie.2021.12.002
DO - 10.1016/j.gie.2021.12.002
M3 - Article
C2 - 35183359
AN - SCOPUS:85125730891
SN - 0016-5107
VL - 95
SP - 827-854.e3
JO - Gastrointestinal endoscopy
JF - Gastrointestinal endoscopy
IS - 5
ER -